Concepedia

William Sheridan

WS

53

Publications

6.1K

Citations

34

H-Index

1985

Active since

Affiliations

BioCryst Pharmaceuticals (United States)(Current)

The Royal Melbourne Hospital

Amgen (United States)

Ludwig Cancer Research

Goethe University Frankfurt

William Sheridan is an author at BioCryst Pharmaceuticals (United States) specializing in medicine, immunology, and hematology.

Top concepts

MedicineImmunologyHematologyPharmacologyOncologyVirologyPathologyImmunotherapyHealthInflammation

Publications per year

1985–2022

53

Publications

53

Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy

William Sheridan, R. M. Fox, C. Glenn Begley et al. · The Lancet · 1992 · 879 citations

Peripheral-blood Progenitor Cells, Thrombosis, Thrombopoiesis +13

EFFECT OF GRANULOCYTE COLONY STIMULATING FACTOR ON NEUTROPENIA INDUCED BY CYTOTOXIC CHEMOTHERAPY

George Morstyn, John Keech, William Sheridan et al. · The Lancet · 1988 · 734 citations

Inflammation, Granulocyte, Medicine +6

Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430

Travis K. Warren, Jay Wells, Rekha G. Panchal et al. · Nature · 2014 · 597 citations · Full text

Viral Diagnostics, Viral Pathogenesis, Immunology +7

GRANULOCYTE COLONY-STIMULATING FACTOR AND NEUTROPHIL RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE MARROW TRANSPLANTATION

William Sheridan, M Wolf, Julie Lusk et al. · The Lancet · 1989 · 430 citations

Cell Therapy, Transplantation, Autoimmune Disease +10

Effects of Polyethylene Glycol–Conjugated Recombinant Human Megakaryocyte Growth and Development Factor on Platelet Counts after Chemotherapy for Lung Cancer

Michael Fanucchi, John A. Glaspy, Jeffrey Crawford et al. · New England Journal of Medicine · 1997 · 293 citations · Full text

Rows per page

1–5 of 53